The drugs have the potential to treat multiple cancers, but Amphora declined to release details about the drugs.
The company released no financial information or terms of the deal, which was negotiated by the Bay Area business unit. The laboratory work to discover the cancer drugs was done by the Durham business unit. Amphora split into two business units about five months ago.
Based in Durham, Amphora uses an automated method to screen chemical libraries quickly and inexpensively. The resulting data helps pinpoint chemicals that hold promise as medicines.
http://www.newsobserver.com/104/story/530481.html
